Market Capitalization (Millions $) |
2 |
Shares
Outstanding (Millions) |
1 |
Employees |
- |
Revenues (TTM) (Millions $) |
0 |
Net Income (TTM) (Millions $) |
-25 |
Cash Flow (TTM) (Millions $) |
-18 |
Capital Exp. (TTM) (Millions $) |
0 |
Cyclacel Pharmaceuticals Inc
Cyclacel Pharmaceuticals Inc is a biopharmaceutical company that focuses on the development of innovative drugs to treat various types of cancers and other serious diseases. The company utilizes its expertise in cell cycle regulation and DNA damage response to develop targeted therapies. Cyclacel Pharmaceuticals aims to improve patient outcomes by developing novel drugs that address the unique biological pathways involved in the development and progression of cancer. The company's drug candidates are designed to inhibit abnormal cell division and promote cell death in cancer cells, while sparing normal healthy cells. Cyclacel Pharmaceuticals is dedicated to advancing its drug candidates through clinical trials with the ultimate goal of providing effective treatment options for patients in need.
Company Address: 200 Connell Drive Berkeley Heights 7922 NJ
Company Phone Number: 517-7330 Stock Exchange / Ticker: NASDAQ CYCC
|